New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On January 4, 2022, Par Pharmaceutical launched an AA-rated generic version of Merz Pharmaceuticals’ Cuvposa (glycopyrrolate) oral solution.
Download PDF
Return to publications
